# Variable Bolus Regimen 1-2-3 for Type 2 Diabetes Mellitus

> **NCT00135083** · PHASE3 · COMPLETED · sponsor: **Sanofi** · enrollment: 347 (actual)

## Conditions studied

- Diabetes Mellitus, Type 2

## Interventions

- **DRUG:** insulin glulisine

## Key facts

- **NCT ID:** NCT00135083
- **Lead sponsor:** Sanofi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-08
- **Primary completion:** —
- **Final completion:** 2007-11
- **Target enrollment:** 347 (ACTUAL)
- **Last updated:** 2011-01-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00135083

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00135083, "Variable Bolus Regimen 1-2-3 for Type 2 Diabetes Mellitus". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00135083. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*